Cases 1 - 10 of 38
AbbVie Inc. et al v. Alembic Pharmaceuticals Limited et al
as 1:2024cv00405
Plaintiff:
AbbVie Inc., Allergan, Inc., Allergan Sales, LLC and others
Defendant:
Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Acerta Pharma B.V. et al v. Alembic Pharmaceuticals Limited et al
as 1:2023cv00548
Plaintiff:
Acerta Pharma B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP and others
Defendant:
Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Actelion Pharmaceuticals US, Inc. et al v. Alembic Pharmaceuticals Limited et al
as 1:2023cv00383
Plaintiff:
Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd and Nippon Shinyaku Co., Ltd.
Defendant:
Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Alcon Inc. et al v. Alembic Pharmaceuticals Ltd. et al
as 1:2023cv00194
Plaintiff:
Alcon Inc. and Alcon Laboratories, Inc.
Defendant:
Alembic Pharmaceuticals Ltd. and Alembic Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Actelion Pharmaceuticals US, Inc. et al v. Alembic Pharmaceuticals Limited et al
as 1:2022cv01450
Plaintiff:
Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd and Nippon Shinyaku Co., Ltd.
Defendant:
Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited et al
as 1:2022cv01395
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Alembic Pharmaceuticals Limited, Alembic Global Holding SA, Alembic Pharmaceuticals, Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Galderma Laboratories, L.P. et al v. Alembic Pharmaceuticals Limited et al
as 1:2022cv01312
Plaintiff:
Galderma Laboratories, L.P. and TCD Royalty Sub LP
Defendant:
Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Array BioPharma, Inc. v. Alembic Pharmaceuticals Limited
as 1:2022cv01277
Plaintiff:
Array BioPharma, Inc.
Defendant:
Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AstraZeneca AB et al v. Alembic Pharmaceuticals Ltd. et al
as 1:2022cv01216
Plaintiff:
AstraZeneca AB and AstraZeneca Pharmaceuticals LP
Defendant:
Alembic Pharmaceuticals Ltd. and Alembic Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Acerta Pharma B.V. et al v. Alembic Pharmaceuticals Limited
as 1:2022cv00154
Plaintiff:
Acerta Pharma B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP and others
Defendant:
Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
